Clinical Trial Results:
            A phase IA/II, multi-center, open-label study of HCD122 administered intravenously once weekly for four weeks in adult patients with advanced non-Hodgkin's or Hodgkin's lymphoma who have progressed after at leastr two prior therapies
    
|     Summary | |
|     EudraCT number | 2007-004888-22 | 
|     Trial protocol | BE DE FR GB | 
|     Global completion date | 
                                    06 Feb 2013
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    15 Dec 2016
                             | 
|     First version publication date | 
                                    15 Dec 2016
                             | 
|     Other versions | |
|     Summary report(s) | CHCD122A2103.CTR.02Nov2016 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
